Other
Treasury stock, value, acquired
Humana Treasury stock, value, acquired increased by 10700.0% to $108.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1100.0%, from $9.00M to $108.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ3 2021
Last reportedQ1 2026Apr 29, 2026
How to read this metric
High levels of repurchases often signal management's confidence in the company's stock value and a commitment to returning capital to shareholders.
Detailed definition
This metric measures the total cash outflow used by the company to repurchase its own shares from the open market. It is...
Peer comparison
Standard metric for capital return programs across all sectors.
Metric ID:
other_treasury_stock_value_acquired_cost_methodHistorical Data
13 periods
| Q3 '21 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00M | $4.00M | $4.00M | $94.00M | $534.00M | $383.00M | $723.00M | $50.00M | $1.00M | $9.00M | $100.00M | $1.00M | $108.00M |
| QoQ Change | — | +33.3% | +0.0% | >999% | +468.1% | -28.3% | +88.8% | -93.1% | -98.0% | +800.0% | >999% | -99.0% | >999% |
| YoY Change | — | — | +33.3% | — | >999% | >999% | +669.1% | -90.6% | -99.7% | -98.8% | +100.0% | +0.0% | >999% |
Range$1.00M – $723.00M
CAGR+230.2%
Avg YoY Growth>999%
Median YoY Growth+66.7%
Treasury stock, value, acquired at Other Companies
Frequently Asked Questions
- What is Humana's treasury stock, value, acquired?
- Humana (HUM) reported treasury stock, value, acquired of $108.00M in Q1 2026.
- How has Humana's treasury stock, value, acquired changed year-over-year?
- Humana's treasury stock, value, acquired increased by 1100.0% year-over-year, from $9.00M to $108.00M.
- What does treasury stock, value, acquired mean?
- The total cost incurred by the company to buy back its own shares.